EUVIMEDEUVIMED entdecken
Crossref

The CF Quantum Sweat Test: Not Ready for Clinical Use

Michael Rock, Vicky LeGrys

American Society for Clinical Laboratory Science · 2020-04 · 33 (2) · 6-13

DOI: 10.29074/ascls.2019002105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Society for Clinical Laboratory Science, online erschienen am 27.04.2023. Verfasst von Michael Rock und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cystic fibrosis (CF) Quantum test (CFQT) showed promise in a previous pilot study; however, there was greater imprecision in one patch lot. Following the pilot study, the manufacturer changed their fabricating procedures. Participants with previously diagnosed CF or participants who required a sweat test for clinical reasons were invited to undergo the CFQT research test and a conventional sweat test (Macroduct collection and chloride analysis via the ChloroChek chloridometer). Previously diagnosed CF (n = 41) and CF transmembrane regulator–related metabolic syndrome/CF screen positive inconclusive diagnosis (n = 3) patients and patients who required a sweat test for clinical indications (n = 22) were recruited to have bilateral CFQT along with the Macroduct test performed on the same day. Pairs of data from each test were plotted as a correlation graph, bias plot, and Bland Altman plot. Coefficient of variation (CV) between extremities and quantity-not-sufficient (QNS) rates for both tests were calculated. The CV between left and right extremities was greater in the CFQT (9.5%) compared with the Macroduct (4.8%). The QNS rates of the two tests were comparable (CFQT, 6.8%; Macroduct, 6.0%). There was greater imprecision with the CFQT results. The diagnostic agreement between the two tests was 100% positive percent agreement (95% confidence interval [CI], 90%–100%), 100% negative percent agreement (95% CI, 80%–100%), 67% intermediate percent agreement (95% CI, 30%–80%), and 92% overall percent agreement (95% CI, 80%–100%). This follow-up study demonstrated that the CFQT is not analytically nor diagnostically reliable (Clinicaltrials.gov identifier NCT01345617).

Zitieren

APA

Rock, M., & LeGrys, V. (2020). The CF Quantum Sweat Test: Not Ready for Clinical Use. American Society for Clinical Laboratory Science, 33(2), 6-13. https://doi.org/10.29074/ascls.2019002105

Vancouver

Rock M, LeGrys V. The CF Quantum Sweat Test: Not Ready for Clinical Use. American Society for Clinical Laboratory Science. 2020;33(2):6-13. doi:10.29074/ascls.2019002105

BibTeX
@article{Rock2020,
  author = {Rock, Michael and LeGrys, Vicky},
  title = {The CF Quantum Sweat Test: Not Ready for Clinical Use},
  journal = {American Society for Clinical Laboratory Science},
  year = {2020},
  volume = {33},
  number = {2},
  pages = {6--13},
  doi = {10.29074/ascls.2019002105}
}
Kostenlos starten →